Scholarlink

<p>Mucopolysaccharidosis type II (or Hunter syndrome) is a lysosomal disease caused by mutations in the <i>IDS</i> gene, which encodes the enzyme iduronate 2-sulfatase. MPS II patients present with systemic clinical manifestations and, in the most severe cases, with severe central nervous system abnormalities. Cardiac alterations are also commonly observed. In this study, we evaluated the communication between mitochondria and lysosomes, as well as mitochondrial dynamics and bioenergetics, mitophagy/autophagy, and redox homeostasis in the cerebral cortex and heart of 6-month-old MPS II mice. Our findings showed a reduction in the content of protein TBC1D15 in the cerebral cortex and heart of MPS II mice and an increase in Rab7 in the heart of these animals, suggesting disturbances in the communication between mitochondria and lysosomes. Furthermore, decreased Drp1 levels, indicative of reduced fission, and increased VDAC1 and COX IV, suggesting an increase in mitochondrial mass, were seen in both tissues. Tom20 was also augmented in the cortex. Changes in parkin levels were also verified, indicating disrupted mitophagy. In the field of bioenergetics, we observed reduced activities of citrate synthase and malate dehydrogenase in the cortex, as well as decreased activities of isocitrate dehydrogenase, creatine kinase, and pyruvate kinase, along with diminished mitochondrial respiration in the cardiac tissue of deficient mice. However, a mild increase in lipid peroxidation was seen only in the heart. Our findings suggest that mitochondria-lysosome crosstalk disruption and bioenergetic failure contribute to the pathophysiology of brain and heart alterations in MPS II.</p> Graphical Abstract <p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Disturbances in mitochondrial quality control and mitochondria-lysosome contact underlie the cerebral cortex and heart damage of mucopolysaccharidosis type II mice

  • 期刊论文

  • 发表日期：

    2025年4月12日

查看全文
  • Camila Vieira Pinheiro,
  • Rafael Teixeira Ribeiro,
  • Ana Cristina Roginski,
  • Morgana Brondani,
  • Ângela Beatris Zemniaçak,
  • Chrístofer Ian Hernandez Hoffmann,
  • Adriana Fernanda K. Vizuete,
  • Carlos-Alberto Gonçalves,
  • Alexandre Umpierrez Amaral,
  • Moacir Wajner,
  • Guilherme Baldo,
  • Guilhian Leipnitz

摘要

Mucopolysaccharidosis type II (or Hunter syndrome) is a lysosomal disease caused by mutations in the IDS gene, which encodes the enzyme iduronate 2-sulfatase. MPS II patients present with systemic clinical manifestations and, in the most severe cases, with severe central nervous system abnormalities. Cardiac alterations are also commonly observed. In this study, we evaluated the communication between mitochondria and lysosomes, as well as mitochondrial dynamics and bioenergetics, mitophagy/autophagy, and redox homeostasis in the cerebral cortex and heart of 6-month-old MPS II mice. Our findings showed a reduction in the content of protein TBC1D15 in the cerebral cortex and heart of MPS II mice and an increase in Rab7 in the heart of these animals, suggesting disturbances in the communication between mitochondria and lysosomes. Furthermore, decreased Drp1 levels, indicative of reduced fission, and increased VDAC1 and COX IV, suggesting an increase in mitochondrial mass, were seen in both tissues. Tom20 was also augmented in the cortex. Changes in parkin levels were also verified, indicating disrupted mitophagy. In the field of bioenergetics, we observed reduced activities of citrate synthase and malate dehydrogenase in the cortex, as well as decreased activities of isocitrate dehydrogenase, creatine kinase, and pyruvate kinase, along with diminished mitochondrial respiration in the cardiac tissue of deficient mice. However, a mild increase in lipid peroxidation was seen only in the heart. Our findings suggest that mitochondria-lysosome crosstalk disruption and bioenergetic failure contribute to the pathophysiology of brain and heart alterations in MPS II.

Graphical Abstract